Sirtex Medical Inc.

Sirtex is a company specializing in the manufacture of SIR-Spheres® Y-90 resin microspheres, which are medical devices indicated for the treatment of unresectable hepatocellular carcinoma (HCC) and unresectable metastatic liver tumors from primary colorectal cancer in patients who are refractory to or intolerant of chemotherapy. Their products are primarily intended for use by healthcare practitioners and patients outside certain regions due to regulatory restrictions.